Anzeige
Mehr »
Login
Samstag, 11.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
313 Leser
Artikel bewerten:
(1)

Hiru Corp. - OTC Pink Current Status and Level 2 Quotes

Finanznachrichten News

PHOENIX, AZ / ACCESSWIRE / June 25, 2021 / Hiru Corp. (the 'Company' or 'HIRU' - OTC PINK:HIRU) - HIRU is pleased to announce today that the OTC Markets Group, Inc. ('OTC Markets') has approved HIRU as 'Pink Sheet Current' as it is now filed all required mandatory quarterly disclosure filings. This upgrade is a direct result of a concerted team effort of the Company's management along with the compliance team that has been assembled.

The Company has filed its annual disclosure statements for the fiscal years December 31, 2019, December 31, 2020, as well as the first quarter ended March 31, 2021. Additionally, the Company's has posted the required financial statements for such same periods and the required omnibus Attorney Opinion ('Current Information') for each of the above listed periods.

Kathryn Gavin (HIRU Sole Officer and Director) stated... 'This is the first time in over four years that HIRU has not traded under a 'Caveat Emptor' notice to investors as issued by OTC Markets and a designation of Pink Sheet No Information. This is obviously a big day for the Company and its shareholders.'

The Company has also purchased Level 2 real time quotes for its landing page on OTC Markets web site. This service will provide investors with up to the date, real time bid and ask quotes during trading hours. This OTC Market service is now active.

Kathryn Gavin (HIRU Sole Officer and Director) further stated... 'In passing, the Company has purchased Level 2 quotes for its landing page with OTC Markets so that our shareholders can stay up to date on the current real time market price of our common stock. Again, we here at HIRU know how important our shareholders are to our future plans of action. Now it is time to get to the real business of the Company, acquiring cash flow positive business assets. As we grow the future business of the Company, we want our public shareholders to understand that we have one goal in mind, to maximize shareholder value.'

The Company now will set out on to identify and acquire the appropriate business entities to grow its future revenue base. As of the date of this press release, the Company has identified several potential acquisitions and we are now in the process of conducting proper due diligence and negotiating final acquisition terms and conditions. The criteria for business acquisition are quite simple, the Company is looking for seasoned, cash flow positive business entities that are operating in a high growth industry.

About Us

Hiru Corp. is a Georgia corporation, is a public quoted Pink Sheet issuer under the ticker symbol 'HIRU' which is currently listed as Pink Sheet Current with OTC Markets, Inc.

Forward Looking Statement

Certain statements that we make may constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning future strategic objectives, business prospects, anticipated savings, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions, demand for and pricing of our products, acquisitions and divestitures, anticipated results of litigation and regulatory developments or general economic conditions. In addition, words such as believes, expects, anticipates, intends, plans, estimates, projects, forecasts, and future or conditional verbs such as will, may, could, should, and would, as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. Forward-looking statements are not guarantees, and they involve risks, uncertainties and assumptions. Although we make such statements based on assumptions that we believe to be reasonable, there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks described in our filings with the Securities and Exchange Commission from time to time, including our most recent Annual Report and subsequent Flings, which are available on Otcmarkets.com. We expressly disclaim any obligation to update any forward-looking statement in the event it later turns out to be inaccurate, whether as a result of new information, future events or otherwise.

CONTACT:
Address: 3331 North 35th Avenue
Phoenix, Arizona 95107
Web Site: www.waterandiceshop.com
Twitter: https://twitter.com/hirucorp
Phone: 928-408-4486
Email: info@waterandiceshop.com
Contact: Kathryn Gavin, CEO

SOURCE: Hiru Corp.



View source version on accesswire.com:
https://www.accesswire.com/653126/Hiru-Corp--OTC-Pink-Current-Status-and-Level-2-Quotes

© 2021 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.